Received Aug 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 4T443 | IM / LA |
Patient given Arexvy instead of Abrysvo. Pt reports EGA 35+2. Patient at risk of adverse event due to side effects of pregnant patient receiving Arexvy. Patient remained at clinic for one hour after event. Patient did not report any s/s of preterm labor. Patient's OB provider made aware of incident. Pt reports that her OB provider would call her to discuss what happened, possible side effects, precautions, and next steps. Incident also reported to (withheld) Clinical Consult Team (phone# withheld opt.1).
Unknown
Unknown
Prenatal Vitamin
No listed food or drug allergies listed.
No known medical test or laboratory results related to this event.